Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children.

Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children.

Publication date: Oct 16, 2024

The kinetics and durability of T-cell responses to SARS-CoV-2 in children are not well characterized. We studied a cohort of children aged 6 months to 20 years with COVID-19 in whom peripheral blood mononuclear cells and sera were archived at approximately 1, 6, and 12 months after symptom onset. We compared antibody responses (n = 85) and T-cell responses (n = 30) to nucleocapsid (N) and spike (S) glycoprotein over time across 4 age strata: 6 months to 5 years and 5-9, 10-14, and 15-20 years. N-specific antibody responses declined over time, becoming undetectable in 26 (81%) of 32 children by approximately 1 year postinfection. Functional breadth of anti-N CD4+ T-cell responses also declined over time and were positively correlated with N-antibody responses (Pearson r = .31, P = .008). CD4+ T-cell responses to S displayed greater functional breadth than N in unvaccinated children and, with neutralization titers, were stable over time and similar across age strata. Functional profiles of CD4+ T-cell responses against S were not significantly modulated by vaccination. Our data reveal durable age-independent T-cell immunity to SARS-CoV-2 structural proteins in children over time following COVID-19 infection as well as S-antibody responses in comparison with declining antibody responses to N.

Concepts Keywords
Blood Adolescent
Cd4 Antibodies, Neutralizing
Nucleocapsid Antibodies, Neutralizing
Recent Antibodies, Viral
Vaccination Antibodies, Viral
CD4-Positive T-Lymphocytes
Child
Child, Preschool
children
Coronavirus Nucleocapsid Proteins
Coronavirus Nucleocapsid Proteins
COVID-19
COVID-19
Female
Humans
Infant
Kinetics
Male
nucleocapsid phosphoprotein, SARS-CoV-2
Phosphoproteins
Phosphoproteins
SARS-CoV-2
SARS-COV-2 nucleocapsid antibody
SARS-COV-2 spike antibody
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
T-Lymphocytes
Young Adult

Semantics

Type Source Name
disease IDO cell
disease MESH COVID-19
disease IDO blood
disease IDO symptom
disease MESH infection

Original Article

(Visited 4 times, 1 visits today)